Thermax Limited has officially announced the sale of its stake in Covacsis Technologies Private Limited. This transaction, completed through a Share Purchase Agreement with Infinite Uptime Inc., USA, results in Covacsis ceasing to be an associate company of Thermax. The sale, executed under SEBI’s Listing Obligations and Disclosure Requirements (LODR) Regulations, signifies a strategic decision by the company.
As per the disclosure made to the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), the agreement for the sale was signed on 3rd April 2025, with the transaction set for completion on 4th April 2025. The stake was sold for approximately ₹10 crores, and Covacsis had incurred a loss of ₹1.79 crores in FY 2023-24, of which ₹0.30 crores was consolidated into Thermax’s financials. The transaction does not fall under related party transactions, and the buyer is not associated with Thermax’s promoter group.
Thermax Limited has ensured full compliance with SEBI’s regulatory framework, particularly Regulation 30 of the SEBI (LODR) Regulations, 2015. The sale does not involve a slump sale or a Scheme of Arrangement. By divesting its stake in Covacsis, Thermax aims to realign its investment strategy, focusing on core business areas. This move reflects the company’s intent to streamline operations and optimise financial performance.
As of April 04 2025, at 9:50 AM, Thermax share price was trading at ₹3,475.40, reflecting a decline of 2.09% from its previous closing price. Over the past month, it has surged by 8.46%.
The sale of Thermax Limited’s stake in Covacsis Technologies marks a significant corporate development. By executing this transaction, Thermax has restructured its investment portfolio while maintaining compliance with SEBI’s regulations. The move highlights the company’s strategic focus on financial prudence and operational efficiency.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Apr 4, 2025, 3:31 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates